Evolution of Diagnosis and Monitoring for Liver FibrosisPart of Medscape Activities: Clinical Advances in the Evolution of Laboratory Diagnostics

Medscape Education Gastroenterology

Dr. Younossi and expert panel provide an overview of the importance of liver fibrosis in NASH and timely noninvasive screening options. The goal of this activity is to highlight best practice in diagnosing and monitoring liver fibrosis and to improve physician confidence in their ability to use noninvasive techniques to identify patients at risk of liver fibrosis progression.

  • Know the guideline recommendations for screening, prognosis, and diagnosis of liver fibrosis
  • Learn the appropriate diagnostic and monitoring techniques for liver fibrosis
  • Gain more confidence in using noninvasive techniques in clinical practice to identify patients with advanced fibrosis

Expert Panel 


Zobair Younossi, MD

Vice President of Research Inova Health System
Falls Church, Virginia, United States


Jörn Schattenberg, MD

Director, Metabolic Liver Research Program
Johannes Gutenberg-Universität Mainz
Mainz, Germany

Jerome Boursier, MD

Academic Hepatologist
University of Angers
Angers, France

Mazen Noureddin, MD

Director, Cedars-Sinai Fatty Liver Program
Cedars-Sinai Medical Center
Los Angeles, California, United States